Epicardial adipose tissue and insulin resistance in patients with coronary artery disease with or without left ventricular dysfunction

Published: December 30, 2013
Abstract Views: 1467
PDF: 836
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.


Background. Epicardial adipose tissue (EAT) is a visceral fat that fulfills two important functions: lipid-storage and secretion of adipokines with pro-inflammatory and pro-atherogenic properties. It has been suggested that EAT may affect the pathogenesis of atherosclerosis and the clinical course of coronary artery disease (CAD). In patients with obesity, diabetes and metabolic syndrome, the epicardial adipose tissue is enlarged. Little is known about the role of EAT in left ventricular dysfunction. Aim of this study was to evaluate the ability of insulin resistance to predict EAT thickness in patients with significant CAD and systolic dysfunction. Methods. We enrolled 114 subjects diagnosed with CAD by angiography. The majority underwent revascularization after an acute coronary syndrome. Patients were considered affected by significant left ventricular dysfunction when EF was



PlumX Metrics


Download data is not yet available.


How to Cite

Baldasseroni, Samuele, Alessandra Pratesi, Francesco Orso, Claudia Di Serio, Alice Foschini, Andrea Giosafat Marella, Nadia Bartoli, Mauro Di Bari, Stefano Fumagalli, Niccolò Marchionni, and Francesca Tarantini. 2013. “Epicardial Adipose Tissue and Insulin Resistance in Patients With Coronary Artery Disease With or Without Left Ventricular Dysfunction”. Monaldi Archives for Chest Disease 80 (4). https://doi.org/10.4081/monaldi.2013.19.